- GBP/USD has been under mild pressure as US yields boost the dollar.
- Britain's reopening and calm on the vaccine front are helping boost sterling.
- Tuesday's four-hour chart is painting a mixed picture.
"Nobody is safe until everybody is safe" – these words of unity from UK Prime Minister Boris Johnson and his colleagues in Germany and France have come after a cross-Channel row over vaccines and serve to calm nerves and supports sterling. Concerns about deliveries of inoculations have now subsided.
Even if the UK's immunization campaign somewhat slows down, it has reached nearly 50% of the population with at least one dose and the results are clear – cases and hospitalizations are falling. Moreover, London recorded no COVID-19 deaths on Monday – the first such feat in 2021.
The comparison to continental Europe is overwhelming, but Britain is also beating the US –not only vaccinations but also in infections. America's CDC warned of an "impending doom" despite the rapid immunization drive.
On the other hand, the dollar is on the move, gaining ground alongside higher bond yields. President Joe Biden is set to unveil his infrastructure spending plan on Wednesday and he may refrain from introducing new taxes in the first phase. That implies higher debt, more bond issuance, and therefore rising returns on Uncle Sam's IOUs.
Moreover, the White House grand plans – which include huge wind farms and other green initiatives – may push inflation higher. If the Federal Reserve is forced to hike borrowing costs, that would also support the greenback.
A gauge of how Americans feel about the recovery comes from the Conference Board's Consumer Confidence measure for March. An increase is on the cards.
All in all, the dollar has reasons to rise, but the UK may overcome such strength thanks to its virus/vaccine advantage.
GBP/USD Technical Analysis
Pound/dollar is trading below the 50, 100 and 200 Simple Moving Average on the four-hour chart but is benefiting from upside momentum. The RSI is stable.
Support awaits at 1.3740, the daily low, followed by 1.37, a round number. The March low of 1.3670 is the next cushion to watch.
Some resistance awaits at 1.3780, a support line from early March. It is followed by 1.3820, a separator of ranges from last week, and then by 1.3845, which worked in both directions in recent weeks.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.